Association of the phosphodiesterase 4D (PDE4D) gene and cardioembolic stroke in an Australian cohort

International Journal of Stroke

Volumn 6, Issue 6, 2011, Pages 480-486

  Milton, Austin G ^a,b   Aykanat, Verna M ^a   Hamilton Bruce, M Anne ^a,b   Nezic, Mark ^a   Jannes, Jim ^a,b   Koblar, Simon A ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Atherothrombotic; Cerebral infarction; Ischemic stroke; Stroke; Stroke subtypes; Vascular events

Indexed keywords

PHOSPHODIESTERASE 4D; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AUSTRALIA; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HEART ATRIUM FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; AGED, 80 AND OVER; ALLELES; AUSTRALIA; BRAIN ISCHEMIA; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; DNA; DNA PRIMERS; EMBOLISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE;

EID: 82255183803     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00616.x     Document Type: Article

References (38)

1. Kiely D, Wolf P, Cupples L, Beiser A, Myers R. Familial aggregation of stroke. The Framingham Study. Stroke 1993; 24:1366-71.
2. Liao D, Myers R, Hunt S et al. Familial history of stroke and stroke risk: the Family Heart Study. Stroke 1997; 28:1908-12.
3. Hertzberg VS, Stern BJ, Sherman S. Analytic strategies for stroke genetics. J Stroke Cerebrovasc Dis 2002; 11:272-8.
4. Gretarsdottir S, Sveinbjörnsdottir S, Jonsson H et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet 2002; 70:593-603.
5. Gretarsdottir S, Thorleifsson G, Reynisdottir ST et al. The gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2003; 35:131-8.
6. Torphy TJ. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998; 157:351-70.
7. Houslay MD, Baillie GS. The role of ERK2 docking and phosphorylation of PDE4 cAMP phosphodiesterase isoforms in mediating cross-talk between the cAMP and ERK signalling pathways. Biochem Soc Trans 2003; 31 (Part 6): 1186-90.
8. Netherton SJ, Maurice DH. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis. Mol Pharmacol 2005; 67:263-72.
9. Netherton SJ, Sutton JA, Wilson LS, Carter RL, Maurice DH. Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells. Circ Res 2007; 101:768-76.
10. Palmer D, Tsoi K, Maurice DH. Synergistic inhibition of vascular smooth muscle cell migration by phosphodiesterase 3 and phosphodiesterase 4 inhibitors. Circ Res 1998; 82:852-61.
11. Blease K, Burke-Gaffney A, Hellewell PG. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4. Br J Pharmacol 1998; 124:229-37.
12. Indolfi C, Avvedimento EV, Di Lorenzo E et al. Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat Med 1997; 3:775-9.
13. Bevan S, Dichgans M, Gschwendtner A, Kuhlenbaumer G, Ringelstein EB, Markus HS. Variation in the PDE4D gene and ischemic stroke risk. A systematic review and meta-analysis on 5200 cases and 6600 controls. Stroke 2008; 39:1966-71.
14. Munshi A, Kaul S. Stroke genetics - focus on PDE4D gene. Int J Stroke 2008; 3:188-92.
15. Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P, Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case-control study in an Indian population. Brain Res Bull 2008; 75:158-65.
16. Munshi A, Babu MS, Kaul S et al. Phosphodiesterase 4D (PDE4D) gene variants and the risk of ischemic stroke in a South Indian population. J Neurol Sci 2009; 285:142-5.
17. Sun Y, Huang Y, Chen X et al. Association between the PDE4D gene and ischaemic stroke in the Chinese Han population. Clin Sci 2009; 117:265-72.
18. Xue H, Wang H, Song X et al. Phosphodiesterase 4D gene polymorphism is associated with ischaemic and haemorrhagic stroke. Clin Sci 2009; 116:335-40.
19. Staton JM, Sayer MS, Hankey GJ et al. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry 2006; 77:1067-9.
20. Jannes J, Hamilton-Bruce MA, Pilotto L et al. Tissue plasminogen activator - 7351C/T enhancer polymorphism is a risk factor for lacunar stroke. [plus comment]. Stroke 2004; 35:1090-4.
21. Hatono S. Experience from a multicentre stroke register: a preliminary report. Bull WHO 1976; 54:541-553.
22. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337:1521-6.
23. Milton AG, Jannes J, Hamilton-Bruce MA, Koblar SA. Activating mutation of the renal epithelial chloride channel ClC-Kb predisposing to hypertension. [comment]. Hypertension 2006; 47:e12; author reply e-3.
24. RCDT: R Development Core Team. R: A Language and Environment for Statistical Computing. ISBN 3-900051-07-0. Vienna, Austria: R Foundation for Statistical Computing, (2008). Available at.
25. Rothman KJ, Greenland S, Lash TL Modern Epidemiology, 3rd edn. Philadelphia: Lippincott Williams and Wilkins, 2008: 261.
26. Gretarsdottir S, Thorleifsson G, Reynisdottir ST et al. Corrigendum: the gene encoding phosphodiesterase 4D confers risk of ischemic stroke. Nat Genet 2005; 37:555.
27. Woo D, Kaushal R, Kissela B et al. Association of phosphodiesterase 4D with ischemic stroke: a population-based case-control study. Stroke 2006; 37:371-6.
28. Lovkvist H, Smith JG, Luthman H et al. Ischaemic stroke in hypertensive patients is associated with variations in the PDE4D genome region. Eur J Hum Genet 2008; 16:1117-25.
29. Zee RYL, Brophy VH, Cheng S, Hegener HH, Erlich HA, Ridker PM. Polymorphisms of the phosphodiesterase 4D, cAMP-specific (PDE4D) gene and risk of ischemic stroke: a prospective, nested case-control evaluation. Stroke 2006; 37:2012-7.
30. Kostulas K, Gretarsdottir S, Kostulas V et al. PDE4D and ALOX5AP genetic variants and risk for ischemic cerebrovascular disease in Sweden. J Neurol Sci 2007; 263:113-7.
31. Rosand J, Bayley N, Rost N, de Bakker PIW. Many hypotheses but no replication for the association between PDE4D and stroke. Nat Genet 2006; 38:1091-2.
32. Song Q, Cole JW, O'Connell JR et al. Phosphodiesterase 4D polymorphisms and the risk of cerebral infarction in a biracial population: the Stroke Prevention in Young Women Study. Hum Mol Genet 2006; 15:2468-78.
33. Bevan S, Porteous L, Sitzer M, Markus HS. Phosphodiesterase 4D gene, ischemic Stroke, and asymptomatic carotid atherosclerosis. Stroke 2005; 36:949-53.
34. Xu X, Li X, Li J, Ou R, Sheng W. Meta-analysis of association between variation in the PDE4D gene and ischemic cerebral infarction risk in Asian populations. Neurogenetics 2010; 11:327-33.
35. Kessler C, Mitusch R, Guo Y, Rosengart A, Sheikhzadeh A. Embolism from the aortic arch in patients with cerebral ischemia. Thromb Res 1996; 84:145-55.
36. Amarenco P, Cohen A, Hommel M, Moulin T, Leys D, Bousser M. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med 1996; 334:1216-21.
37. Macleod MR, Amarenco P, Davis SM, Donnan GA. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 2004; 3:408-14.
38. Zavala JA, Amarenco P, Davis SM et al. Aortic arch atheroma. Int J Stroke 2006; 1:74-80.